Aclaris Therapeutics, Inc. - Netong Asset Bawat Isang Bahagi ACRS
Ang price chart ng Aclaris Therapeutics (ACRS) ay sumasalamin sa performance ng isang kumpanya na ang mga pag-unlad ng immunological drug ay kasalukuyang nasa testing phase, na nagreresulta sa hindi maabot na commercial growth dahil sa mataas na gastos sa R&D. Ang kasalukuyang halaga ng metric ay 0.90, habang walang operating income at ang mga aktibidad ay pinapanatili sa pamamagitan ng external funding. Ang negosyo ay nakatuon sa pagbuo ng mga dermatology therapy, na naglalayong targetin ang merkado ng skin treatment.
aclaristx.com - mga analytical breakdown at pangunahing sukatan (ACRS)
- presyo at pagtataya ng pinagkasunduang presyo:
- datos sa market capitalization:
- datos sa book capitalization:
- datos sa utang at liquidity:
Kabuuang Utang sa Kapital Aclaris Therapeutics|ACRS - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Aclaris Therapeutics, Inc.|ACRS - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Aclaris Therapeutics, Inc.|ACRS - Mga pangmatagalang pananagutan ng kumpanya|Mga panandaliang utang ng kumpanya Aclaris Therapeutics
Fundamental valuation ng kumpanya:Aclaris - ACRS
Ang book value per share ay sumasalamin sa bahagi ng net assets na nauugnay sa isang solong security at nagsisilbing indikasyon ng intrinsic value ng issuer sa oras ng liquidation. Sa pamamagitan ng pagsusuri sa book value per share ratio, maaaring matasa ng isang investor ang resource capitalization ng Aclaris Therapeutics (ACRS), na, sa clinical trial stage sa immunology, ay limitado ng mga gastos sa bioreagent at pagsunod sa mga environmental disposal protocol.
Mga kakumpitensya ng Aclaris Therapeutics (ACRS)
Netong Asset Bawat Isang Bahagi Argenx (ARGX)|BNTX: Accounting Value ng Bahagi|Abivax Corp - Netong Asset Bawat Isang Bahagi|ADMA (admabiologics.com) - Net Assets Bawat Bahagi|Netong Asset Bawat Isang Bahagi Protagonist PTGX|Book Value ng Bahagi Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value Bawat Bahagi|Accounting Value ng Bahagi Grifols Biemat (GRFS)|Book Value Bawat Bahagi ADPT (Adaptive Biotechnologies)|celldex.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value ng Bahagi|VERA (Vera Pharma) - Netong Asset Bawat Isang Bahagi|Dianthus Corp (DNTH) - Accounting Book Value Bawat Bahagi|PHVS (Pharvaris N.V.) - Book Value Bawat Bahagi|Book Value Bawat Bahagi AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi Precigen Inc (PGEN)|Book Value Bawat Bahagi PHAR|Nektar Corp - Net Assets Bawat Bahagi|UPB: Netong Asset Bawat Isang Bahagi|ZBIO: Accounting Book Value Bawat Bahagi|IMNM (Immunome) - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi SEPN|Netong Asset Bawat Isang Bahagi Pieris Pharmaceuticals PVLA|Stockholders Equity Bawat Bahagi savarapharma.com (SVRA)|RIGL: Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi AnaptysBio Inc ANAB|Astria Pharma - Book Value Bawat Bahagi|ENGN - Book Value Bawat Bahagi|RAPT (RAPT Therapeutics, Inc.) - Book Value Bawat Bahagi|JBIO (Aerovate Therapeutics) - Accounting Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Kyverna Therapeutics, Inc.|Netong Asset Bawat Isang Bahagi Tiziana Life Sciences Ltd.|Book Value Bawat Bahagi CABA|Book Value Bawat Bahagi VTYX (Ventyx Biosciences, Inc)|Netong Asset Bawat Isang Bahagi Theratechnologies Inc.|Accounting Value ng Bahagi avalotx.com AVTX|Book Value Bawat Bahagi ELDN (Eledon Pharmaceuticals, Inc.)|AGEN: Net Assets Bawat Bahagi|Climb Bio, Inc. - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi Zura Bio Ltd|ATYR - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi Adagene Corp (ADAG)|Accounting Book Value Bawat Bahagi ImageneBio Inc|Book Price ng Bahagi shattucklabs.com (STTK)|Book Value Bawat Bahagi Equillium|Accounting Value ng Bahagi Connect Biopharma Holdings CNTB|IMUX (Immunic Inc) - Book Value Bawat Bahagi|ATRA: Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value ng Bahagi|ACET (Adicet Bio Inc.) - Book Value Bawat Bahagi|Book Value Bawat Bahagi CELU|INMB - Netong Asset Bawat Isang Bahagi|Book Value ng Bahagi barinthusbio.com (BRNS)|KZR: Book Value Bawat Bahagi|SABS - Net Asset Value Bawat Bahagi|Akari Therapeutics plc - Accounting Book Value Bawat Bahagi|Enlivex Therapeutics (ENLV) - Book Value Bawat Bahagi|QTTB - Accounting Book Value Bawat Bahagi|geovax.com (GOVX) - Book Price ng Bahagi|EDSA: Book Value Bawat Bahagi|Net Assets Bawat Bahagi iBio Inc|Book Value Bawat Bahagi CARM (Carisma Therapeutics)|Accounting Book Value Bawat Bahagi XTLB (XTL Bio)|Netong Asset Bawat Isang Bahagi BOLT|Net Assets Bawat Bahagi HCW Biologics, Inc. HCWB|Aptevo - Book Value Bawat Bahagi|AIM - Book Value Bawat Bahagi|ADTX (aditxt.com) - Book Value Bawat Bahagi|GRI (GRI Bio Corporation) - Accounting Book Value Bawat Bahagi|XRTX - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi HIND|REVB (Revelation Biosciences, Inc.) - Netong Asset Bawat Isang Bahagi|Net Assets Bawat Bahagi INDP (Indaptus Therapeutics Inc)|Scinai (SCNI) - Netong Asset Bawat Isang Bahagi|Book Value ng Bahagi CalciMedica Inc CALI|Book Value Bawat Bahagi Affimed Therapeutics (AFMD)|ALLK - Accounting Value ng Bahagi|HOOK: Book Value Bawat Bahagi|IGMS (IGM Biosciences) - Book Value Bawat Bahagi|ITOS - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi OCEA|Netong Asset Bawat Isang Bahagi TCBP (TC Biopharm)|Accounting Book Value Bawat Bahagi thirdharmonicbio.com (THRD)